Αποτελέσματα Αναζήτησης
The results of studies investigating the allergenic risks of formocresol are equivocal. Studies have shown no evidence of an allergic response in non-presensitized animals, 273 and presensitized animals showed only a weak allergic potential. 314 The demonstration of an immune response to formocresol-fixed, autologous tissue implanted in ...
- Pulpotomy
Application of formocresol results in systemic absorption of...
- Pulpotomy
3 Μαΐ 2023 · The current paper aimed to review the properties of formocresol and concerns regarding its safety as a pulpotomy medicament for primary teeth.
Results: No clinical failures were evident in both groups over the 12 months. At nine months, internal resorption was evident in two (6.7%) and three (10%) molars in TheraCal LC and formocresol...
Formocresol. Formocresol has been used in dentistry for over 100 years, and for vital pulpotomy in primary teeth for over 80 years. Its efficacy has been extensively studied, with clinical success rates ranging from 70% to 100%, making it the standard against which newer techniques are compared.
10 Μαρ 2022 · Formocresol was found to have better overall success rates than calcium hydroxide at all time periods and better radiographic success rates at 12 months. Only 12 of the 63 comparisons had suggestive or weak evidence, whereas all others had either negligible evidence or insufficient data.
1 Ιουλ 2008 · Results: Obtained by chi-square test revealed that all the pulpotomized primary molars were asymptomatic till the end of the study period; suggesting 100% clinical and radiographic success while...
29 Δεκ 2022 · We performed this network meta-analysis to determine the comparative efficacy of formocresol (FC), ferric sulfate (FS), sodium hypochlorite (NaOCl), calcium hydroxide (CH), mineral trioxide aggregate (MTA), biodentine, and laser for pulpotomy of molar teeth.
